I AM LIFE

INTERNATIONAL AMYLOIDOSIS MYELOMA AND LYMPHOMA FOUNDATION

 

FIRST INTERNATIONAL CONFERENCE

 ON MYELOMA AND LYMPHOMA

BTG2010-SHANGHAI

 

SEPT 24-26, 2010

SHANGHAI, CHINA

 

EXECUTIVE SUMMARY

 

This first international conference on lymphoma and myeloma �Bridging the Gap 2010� will be held in Shanghai on September 24-26, 2010.  The conference brings together leading authorities in lymphoma and multiple myeloma to present the latest ground breaking findings on cutting edge research and novel treatments.  The discussion forums provide an opportunity to integrate the latest technical and pharmaceutical interventions.  The conference targets lymphoma, myeloma, immunotherapy and stem cell transplant biology.  The target audience is from China, Asia, and the United States.

  

OVERVIEW

 

Cancer is a leading cause of death in China and Asia.  Hematologic malignancies are an increasing subset of the total cancer incidence rate.  It is especially true in lymphoma and myeloma.  In recent years, great improvement in the field of lymphoma and myeloma has taken place with a rapid growth in trained oncologists and cancer centers as well as advancements in diagnostic technology. Most of the advances occurred in the Western countries. There is a need to communicate and integrate conceptual knowledge, disease understanding, therapeutic agent intervention, diagnostic methodologies, supportive care, and management of complications.

 

Since Shanghai is on the leading edge of medicine and especially oncology care, it is an ideal venue for promoting stronger understanding between practitioners and laboratory researchers from different fields and providing a platform for advancing daily clinical practice. This would in turn improve overall quality of cancer treatment, especially in terms of diagnosis and follow up of therapeutic strategies.

 

The main objective of this proposed conference is to educate the practicing oncologists/hematologists about cutting edge treatments for lymphoma and myeloma, conduct open forum for case discussions and provide a platform for the attendees to discuss their ongoing endeavors and above all tie the technical knowhow into the daily practice. This conference will basically forge stronger and more effective lines of communication between Physicians and Laboratory Investigators in a fashion that will yield significant benefits to patients and doctors.

 

Our ultimate goal is to help improve the quality of patient care, set standards of clinical competence for practice and encourage the continuing scholarship required for professional excellence over a lifetime of service.

 

This conference will be an important step towards implementing a new standard of care and uniformity of knowledge which in turn will bring dividends to cancer patients, physicians and future practitioners.

  

OBJECTIVES

 

1.     Identify the existing need for the current medical education of the practicing hematologists with an Asian perspective, and build sessions to address the key areas of need.

2.     Construct methodology for promoting increased awareness, knowledge and integration of     diagnostic tests into daily practice in the field of lymphoma and myeloma in the Asian sector including practice guidelines and the latest therapeutic agents.

3.     Encourage and provide opportunity for clinical and basic research in the field of lymphoma and myeloma.

 

BRIDGING THE GAP � 2010

 

This conference will be an exciting, productive, interactive and educational experience for the attendees.  Top researchers and practitioners from the world over will meet to discuss the current state � and future directions of Lymphoma and Myeloma in the Asian sector and explore opportunities for collaborations in order to further the field. The event promises to be a unique medical education forum for the exchange of critical information as well as analyze the diagnostic and therapeutic challenges faced by the practicing clinicians. It will feature didactic presentations and debates, in which experts will discuss some of the most challenging topics in lymphoma, myeloma, immunotherapy and stem cell transplant, providing a thorough analysis of research breakthroughs and emerging data.

 

 

TARGET AUDIENCE

 

This conference is specifically designed for Hematologists, Oncologists, Transplant Oncologists, Radiation Oncologists, physicians-in-training, and healthcare professionals (nurses, pharmacists, etc) involved in and/or interested in hematologic malignancies and their management. Attendees are expected to be from China and neighboring countries and the United States.

  

SYMPOSIUM ORGANIZERS

China

Shanghai Changzheng Hospital                                                          Shanghai, China

Fudan University Shanghai Cancer Center                                          Shanghai, China

Association of Hematology, China Medical Association                      Shanghai, China

 

USA

International Amyloidosis, Myeloma, Lymphoma Foundation Houston, Texas

University of Texas at MD Anderson Cancer Center                            Houston, Texas

Cornell University                                                                                Ithaca, New York 

ORGANIZING COMMITTEE

China

Changgeng Ruan MD, PhD     

Professor/Academacia

President        

Chinese Hematology   Jiangsu Institute of  Society     Hematology

Suzhou, China

 

Jian Hou MD, PhD                   

Professor/Director       

Hematology                

Changzheng Hospital, Shanghai        

 

Jin Li MD, PhD

Professor/Chairman    

Medical Oncology       

Fudan University Cancer Hospital, Shanghai 

 

USA

Alice Chen, MBA                     

President                    

International Amyloidosis Myeloma Lymphoma

Foundation (I AM LIFE)

 

Larry Kwak MD, PhD               

Professor/Chairman    

Lymphoma/Myeloma  

MD Anderson Cancer Center

 

Richard Champlin MD             

Professor/Chairman    

Stem Cell Transplant  & Cellular Therapy      

MD Anderson Cancer Center

 

Morton Coleman, MD              

Professor/Director       

Lymphoma/Myeloma  

Cornell University

 

Raymond Alexanian MD         

Professor                    

Lymphoma/Myeloma  

MD Anderson Cancer Center

 

Yong-Jun Liu MD, PhD            

Professor/Chairman    

Immunology               

MD Anderson Cancer Center

 

Simrit Parmar, MD                  

Assistant Professor      

Stem Cell Transplant  

MD Anderson Cancer Center & Cellular Therapy        

 

Qing Yi MD, PhD                     

Professor                    

Lymphoma/Myeloma  

MD Anderson Cancer Center

 

Michael (Luhua) Wang MD     

Associate Professor    

Lymphoma/Myeloma  

MD Anderson Cancer Center

  

FACULTY

China

Changgeng Ruan, MD, PhD    

Professor/Academacia

President Chinese Hematology Society

Jiangsu Institute of Hematology

Suzhou, China

 

Jian Hou MD, PhD

Professor

Director of Myeloma Program

Changzheng Hospital, Shanghai        

 

Jianyong Li, MD, PhD

Professor

Director Department of Hematology

Jiangsu Province People�s Hospital, Jiangsu

 

Lugui Qiu, MD

Professor

Department Head of Institute of Hematology

& Hospital of Blood Diseases

Peking Union Medical College

 

Xiaonan Hong, MD

Professor

Department of Chemotherapy

Fudan University Cancer Hospital, Shanghai

 

Secretary ICML 2010

Weijun Fu, MD, PhD

Associate Professor

Hematology

Changzheng Hospital,Shanghai

 

FACULTY

USA

Larry Kwak, MD, PhD

Professor

Chairman Department of Lymphoma/Myeloma

MD Anderson Cancer Center

 

Richard Champlin, MD

Professor

Chairman Department of Stem Cell Transplant  & Cellular Therapy

MD Anderson Cancer Center

 

Morton Coleman, MD

Professor

Director of Lymphoma/Myeloma

Cornell University

 

Raymond Alexanian, MD

Professor

Lymphoma/Myeloma

MD Anderson Cancer Center

 

Yong-Jun Liu, MD, PhD

Professor

Chairman Department of Immunology

MD Anderson Cancer Center

 

Simrit Parmar, MD

Assistant Professor

Department of Stem Cell Transplant & Cellular Therapy

MD Anderson Cancer Center

 

Qing Yi, MD, PhD

Professor

Lymphoma/Myeloma

MD Anderson Cancer Center


Eric Davis, MD, PhD
Associate Professor
Lymphoma/Myeloma
MD Anderson Cancer Center

 

Jorge Romaguera, MD

Professor

Lymphoma/Myeloma

MD Anderson Cancer Center

 

Michael (Luhua) Wang, MD

Associate Professor

Lymphoma/Myeloma

MD Anderson Cancer Center


 

SCIENTIFIC AGENDA

 

Jian Hou, MD, PhD                   The Current treatment on Patients with multiple myeloma in China

Jianyong Li, MD, PhD              The Cytogenetic Characteristic and Treatment of SLL/CLL in China

Lugui Qiu, MD                          The Diagnosis and Treatment of T-Cell Lymphoma in China

Xiaonan Hong, MD                   The Current Situation of treatment on DLBCL in China

Michael Wang, MD                  Multiple Myeloma Treatment Updates

                                                Mantle Cell Lymphoma: Challenges and Updates

Larry Kwak MD, PhD                Immunotherapy in Follicular Lymphoma

Richard Champlin, MD Transplant Options for Mantle cell Lymphoma

Morton Coleman, MD               Pet scan in Lymphoma

Yong-Jun Liu MD, PhD             Translational value of plasma cell dendritic cell in Lymphoma and Myeloma

Qing Yi, MD, PhD                     Immunotherapy in Multiple Myeloma

Simrit Parmar, MD                   Update on Amyloidosis

                                                Role of maintenance therapy post transplant

Changgeng Ruan MD, PhD      TBA

Weijun Fu, MD, PhD                Current status of MM research in China

 

Jia Ruan, MD, PhD                   TBA

Eric Davis, MD, PhD                 BCR Signaling in Lymphoma

Jorge Romaguera, MD MCL Updates on new therapies

 

SYMPOSIUM LOCATION AND REGISTRATION

China Executive Leadership Academy Pudong

99 Qiancheng Road

Pudong New Area, Shanghai 201204

China

 

The campus of CELAP covers an area of 41.26 hectares and possesses a floor area of over 100,000 square meters. Equipped with modern facilities, CELAP can accommodate about 850 full-time students for training at one time. In addition to the splendid administration building and a modern teaching centre which consists of seminar rooms, lecture-rooms, auditoriums, and computer laboratories, CELAP also owns many stylish facilities, including conference center, information center, sports center, international center, dining hall, and campus hotels.

  

The Registration and Information Desk will be staffed:

Friday, September 24, 2010: 7:30 am to 4:30 pm

Saturday, September 25, 2010: 7:30 am to 4:30 pm

 

Target Audience

This conference will be designed for the education of all interested healthcare professionals including hematologists, oncologists, transplantation specialists, pathologists, nurses, pharmacists and students.

  

EXHIBIT BOOTH DETAILS:  To be determined by The Medal Group

 

A) Special design booths        

  •         2.5m x3mx3m booth located in a high traffic area
  •         Company logo, description, and page ad in the program guide
  •         Company listing on Premium Booth signage and BTG2010 Website
  •         4 meeting registrations per exhibit
  •         Admits 2 to BTG2010 networking function
  •         Draped table, 2 chairs, and wastebasket
  

B) Background Display and stand 

  •         2.5m x 3mx3m exhibit booth located in high traffic area
  •         Company logo and description published in the program guide
  •         Company listing on BTG2010 Summit Website
  •         2 meeting registrations per exhibit
  •         Draped table, 2 chairs, and wastebasket
  

C) Standard Shell scheme

  •         2.5m x 3mx3m exhibit booth
  •         Company logo and description published in the program guide
  •         2 meeting registrations per exhibit
  •         Draped table, 2 chairs, and wastebasket
  

SPONSORSHIP OPPORTUNITIES: PLATINUM SUPPORTER $70,000

 

Platinum supporter

  •         Complimentary meeting space for a one hour mini-symposium (time slots will be allocated on a first come first serve basis)
  •         Complimentary meeting space for a one hour Advisory Board meeting focused on thought leader interactions (time slots will be allocated on a first come first serve basis)
  •         Five complementary full conference registrations
  •         Three special invitations to the conference faculty dinner
 

Gold supporter

  •         Complimentary meeting space for a one hour Advisory Board meeting focused on thought  leader interactions (Time slots will be allocated on a first come first serve basis)
  •         Three complementary full conference registrations
  •         Three special invitations to the conference faculty dinner
  •         Acknowledgment of support on program announcement
 

Silver supporter

  •         Acknowledgement of being sole supporter of �Fellows in Training� or �Junior Faculty� Conference Stipends for submitted abstract presenters
  •         Two complementary full conference registrations
  •         Acknowledgment of support on program announcement
  •         Acknowledgment of support on final program announcement

 

Bronze supporter

  •         Listing of your companies name in all conference materials acknowledging your support One complementary full conference registration
  •         Acknowledgment of support on program announcement
  •         Listing of your companies name in all conference materials acknowledging your support